Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3020% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Legacy Neurotechnology & Spine Segment by Year
Legacy Neurotechnology & Spine Segment (through FY2021Q3) — Worldwide Sales ($M) ($M)
Stryker Legacy Neurotechnology & Spine Segment: $2,992M in FY2020, down 2.2% from a year earlier. No newer figure appears in the documents we track.
Latest, FY2020
2,992
Period ended Dec 31, 2020
Change on a year earlier
-2.2%
3,058 in FY2019
History
3 years
Since FY2018
Sources
3
Documents cited below
Where the FY2020 figure comes from
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Legacy Neurotechnology & Spine Segment (through FY2021Q3) — Worldwide Sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2020 | Dec 31, 2020 | 2,992 | -2.2% | 0000310764-21-000005|sykex991earningsq42020.htm ↗ |
| FY2019 | Dec 31, 2019 | 3,058 | +14,461.9% | 0000310764-20-000004|sykex991earningsq42019.htm ↗ |
| FY2018 | Dec 31, 2018 | 21 | – | 0000310764-19-000006|sykex991earnings1292019.htm ↗ |
Cite this data
StockData. (2026). Stryker Legacy Neurotechnology & Spine Segment ($M), annual FY2018–FY2020 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/leg-ns-seg-only
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.